• Lisa YoungeEmail author
  • Nienke Ipenburg


The combination of an ageing population and now recognised second peak of onset of IBD in individuals aged 60 and over means the management of IBD in the older person is becoming ever more important.

Comorbidity and polypharmacy are more likely in this age group which may impact upon management decisions, particularly in regard to the use of immunosuppressant, steroid and biological therapies.

This chapter considers specific considerations for nurses and other healthcare professionals managing the older person with IBD, highlighting appropriate assessment and management skills nurses can develop to play a meaningful role in the management of IBD in the elderly person.


Older person Ageing process Holistic care 


  1. Beard JR, Cassels AK (2016) The world report on ageing and health. Gerontologist 56:S268–S280CrossRefGoogle Scholar
  2. Charpentier C, Salleron J, Savoye G et al (2014) Natural history of elderly onset inflammatory bowel disease: A population-based cohort study. Gut 63:423–432CrossRefGoogle Scholar
  3. Cross RK, Wilson KT, Binion DG (2005) Polypharmacy and Crohn’s disease. Aliment Pharmacol Ther 21:1211–1216CrossRefGoogle Scholar
  4. Delaney CP, Dadvand B, Remzi FH, Church JM, Fazio VW (2002) Functional outcome, quality of life, and complications after ileal pouch-anal anastomosis in selected septuagenarians. Dis Colon Rectum 45:890–894CrossRefGoogle Scholar
  5. Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, Turck D, Cortot A, Peyrin-Biroulet L, Colombel JF (2013) Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis 45:89–94CrossRefGoogle Scholar
  6. Graham JE, Rockwood K, Beattie BL et al (1997) Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349(9068):1793–1796CrossRefGoogle Scholar
  7. Jeuring SF, van den Heuvel TR, Zeegers MP et al (2016) Epidemiology and longterm outcome of inflammatory bowel disease diagnosed at elderly age – an increasing distinct entity? Inflamm Bowel Dis 22:1425–1434CrossRefGoogle Scholar
  8. Navaneethan U, Edminster T, Zhu X et al (2017) Vedolizumab is safe and effective in elderly patients with inflammatory bowel disease. Inflamm Bowel Dis 23:4 E17. CrossRefPubMedGoogle Scholar
  9. Nguyen GC, Sheng L, Benchimol EI (2015) Health care utilization in elderly onset inflammatory bowel disease: A population-based study. Inflamm Bowel Dis 21:777–782CrossRefGoogle Scholar
  10. Nimmons D, Limdi JK (2016) Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther 7(1):51–65CrossRefGoogle Scholar
  11. Panara AJ et al (2014) The incidence and risk factors for developing depression after being diagnosed with IBD. Aliment Pharmacol Ther 39:802–810CrossRefGoogle Scholar
  12. Rao SS (2004) Diagnosis and management of fecal incontinence. Am J Gastroenterol 99:1585–1604CrossRefGoogle Scholar
  13. Siegel CA, Marden SM, Persing SM, Larson RJ, Sands BE (2009) Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn’s disease: A meta-analysis. Clin Gastroenterol Hepatol 7:874–881CrossRefGoogle Scholar
  14. Sturm A, Maaser C, Mendall M et al (2017) European Crohn’s and Colitis Organisation Topical reriew on IBD in the elderly. J Crohn’s Colitis 11(3):263–273Google Scholar
  15. Velonias G, Conway G, Andrews E et al (2017) Older age and health related Quality of Life in inflammatory bowel disease. Inflamm Bowel Dis 23(2):283–288CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.IBD Unit, Royal London Hospital, Barts HealthLondonUK
  2. 2.IJsselland HospitalCapelle aan den IJsselThe Netherlands

Personalised recommendations